文献
J-GLOBAL ID:202002285636600453
整理番号:20A0898179
177LU-DOTATATE治療の治療効果に及ぼすベースライン肝臓腫瘍負荷,アルカリ性ホスファターゼ(ALP)上昇および標的サイズ病変の影響:無増悪生存期間の分析とNETTER-1研究の安全性
Impact of Baseline Liver Tumor Burden, Alkaline Phosphatase (ALP) Elevation, and Target Size Lesion on Therapeutic Effect of 177LU-DOTATATE Treatment: Analysis of Progression Free Survival, and Safety in NETTER-1 Study
著者 (17件):
STROSBERG Jonathan
(Moffitt Cancer Center, FL)
,
KUNZ Pamela
(Stanford Univ., CA)
,
HENDIFAR Andrew
(Cedars Sinai Medical Center, CA)
,
YAO James
(Univ-Texas MD Anderson Cancer, TX)
,
BUSHNELL David
(Univ. Iowa, IA)
,
KULKE Matthew
(Boston Medical Center, MA)
,
BAUM Richard
(Zentralklinik, Bad Berka, DEU)
,
MARTIN Caplin
(Royal Free Hospital, London, GBR)
,
RUSZNIEWSKI Philippe
(Paris Diderot Univ., Paris, FRA)
,
DELPASSAND Ebrahim
(Excel Diagnostics, TX)
,
HOBDAY Timothy
(Mayo Clinic, MN)
,
VERSLYPE Chris
(KU Leuven, Leuven, BEL)
,
BENSON Al
(Robert H. Lurie Comprehensive Cancer Center, IL)
,
POLACK Berna
(Advanced Accelerator Applications, MA)
,
HE Beilei
(Advanced Accelerator Applications, MA)
,
SANTORO Paola
(Advanced Accelerator Applications, MA)
,
KRENNING Eric
(Erasmus Medical Center, Rotterdam, NLD)
資料名:
Pancreas
(Pancreas)
巻:
49
号:
3
ページ:
489
発行年:
2020年03月
JST資料番号:
F2384A
ISSN:
0885-3177
資料種別:
逐次刊行物 (A)
発行国:
日本 (JPN)
言語:
英語 (EN)